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Abstract
Two hundred and eighty six cases of cleft
lip, cleft palate, or both were identified in
a study attempting complete ascertain-
ment of babies with facial clefts born to
women resident in the west of Scotland in
a five year period beginning 1 January
1980. The total birth prevalence (TBP) of
these defects over this period was 1-53 per
1000. The TBP for cleft lip with or with-
out cleft palate (CL[P] was 0-74 per 1000
and for cleft palate (CP) was 0 79 per
1000; 26% of CL[P] and 39-5% of CP cases
had one or more major congenital anom-
aly associated with their facial cleft and
in over half of these cases a specific gen-
etic or syndrome diagnosis could be
made. In comparison to previous Euro-
pean reports this study shows a high inci-
dence of associated abnormalities and a
remarkably low ratio of CL[P]:CP cases.
(J Med Genet 1994;31:126-129)
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Cleft lip with or without cleft palate (CL[P]
and cleft palate (CP) are aetiologically distinct
subgroups of the facial cleft group of anomal-
ies. This distinction has been made on the
basis of the different embryological timings of
primary and secondary palate closure' and
recurrence of the same type of defect within a
family.2"5 There are also epidemiological dif-
ferences between the groups which include an
observed racial variation in the birth preval-
ence of CL[P]-9 but not CP,9"0 an excess of
male cases in most reports of the CL[P]
group,24101' and a slight female excess in the
CP group.'012 The higher incidence of associ-
ated congenital anomalies that has been
reported in subjects with CP compared to
those with CL[P]'314 has also been cited as
evidence of distinct aetiologies for these
groups.
In spite of the differences between these
groups there is evidence suggesting common
factors in their aetiology. Woolf'5 has shown a
small but convincing increase in the occur-
rence of CP in the families of a large cohort of
patients with CL[P]. Rintala'6 reported a re-
markable parallelism in the changes of birth
prevalence of CL[P] and CP over a 27 year
period in the Finnish population. It has also
been noted that families with Van der Woude
syndrome (MIM 119300) may have both types
of defect associated with lip pits segregating in
one pedigree.'7 Finally, a variation in the trans-
forming growth factor a (TGFa) gene has
been found to be over-represented in cohorts
of unrelated subjects with both CL[P] and
CP.18-21
Previous reports of facial clefts in Scot-
land22 23 have suggested that there is a relatively
low incidence of CL[P] and high incidence of
CP in this population compared to the Euro-
pean average. In the present study we have
attempted complete ascertainment of babies
born with facial clefts, within a five year
period, to mothers living in the west of Scot-
land in order to calculate the birth prevalence
of each subgroup. Particular attention was
paid during the study to the number and
nature of associated congenital anomalies and
the specific genetic diagnosis in each of the
subgroups. Data derived from this study are
compared to those reported in other studies of
European populations.
Materials and methods
The study population comprised those infants
born to mothers whose main residence was
within Greater Glasgow, Lanarkshire, Forth
Valley, Dumfries and Galloway, Argyll and
Clyde, or Ayrshire and Arran Health Boards
from 1 January 1980 to 31 December 1984.
The index cases were identified through four
main sources; neonatal discharge forms, hos-
pital admission records, the Glasgow database
for European Registration for Congenital An-
omalies and Twins (EUROCAT), and hospital
diagnostic indices. Follow up information on
index cases with associated abnormalities was
obtained from personal examination, hospital
records, genetic records, and detailed necropsy
reports.
Patients with microforms of facial clefts
(bifid uvula and submucous cleft palate) were
excluded from the study group as the majority
of these defects do not come to medical atten-
tion and would, therefore, require a population
survey for complete ascertainment.2425
A figure for birth prevalence was calculated,
as the common occurrence of facial clefts in
early spontaneous abortions26 would make an
incidence of these defects very difficult to
estimate. Birth prevalence figures were calcu-
lated per 1000 total births (0/,,TB) or live
births (0/,,LB) and quoted with 95% confi-
dence intervals using the methods of Czeizel
and Tusnady.27 Groups were compared using
the X2 test and the Yates correction factor was
used in the two by two contingency tables
(YMX2). Evidence of cyclical trends within the
facial clefts groups were assessed using both
parametric28 and non-parametric rank sum29
methods. Associated congenital anomalies
were assigned to major and minor categories
using the guidelines of Smith.30
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Table 1 Birth prevalence offacial cleft subgroups
Facial cleft Total births TBP Live births LBP
CL[P] 139 0 74 (0-12) 126 0 68 (0-12)
CL 51 0 27 (0-08) 51 0 27 (0-08)
CLP 88 047 (0-10) 75 041 (0-10)
CP 147 0 79 (0-13) 142 0 78 (0-13)
Total 286 1.53 (018) 268 144 (018)
CL = cleft lip only; CLP= cleft lip with cleft palate; CL[P] = cleft lip with or without cleft palate;
CP= cleft palate only; TBP= birth prevalence per 1000 total births (SD 2); LBP= birth
prevalence per 1000 live births (SD 2).
Results
BIRTH PREVALENCE (TABLE 1)
Two hundred and eighty six patients with
CL[P] or CP were identified among the
187321 total births in the study population.
The total birth prevalence (TBP) was thus
estimated as 1-53±0-180/o,. Cleft lip occurred
in 51/286 (17-8%) of the cases, 88/286 (30-8%)
had cleft lip and palate (CLP), and 147/286
(51 4%) had CP; 268/286 (93-7%) of the facial
cleft cases and 186 139/187 321 (99 4%)
of total births were liveborn, so the live
birth prevalence (LBP) can be calculated as
1-44 ± 0- 180/. Of the liveborn patients 51/268
(19-0%) had CL, 75/268 (28-0%) had CLP,
and 142/268 (53 0%) had CP.
NATURE OF CLEFT LIP DEFECT
Of the 139 cases of CL[P] identified, 51/139
(36-7%) had CL and 88/139 (63-3%) had
CLP; 86/139 (61-9%) had unilateral defects,
two cases had midline defects (1-4%), and in
41/139 (29-5%) the defect was bilateral. In 10
cases (7 2%) the nature of the lip defect was
not recorded. In the unilateral CL[P] cases
(where laterality was recorded) left sided
defects were significantly more common,
accounting for 55/86 (63-9%) of this group
(X2=6-7, p<0-01).
SEX DIFFERENCES (TABLE 2)
There was a statistically significant excess of
males (90/139, 64-7%) among all CL[P] cases
(YMX2=8-36, p<0-01) giving a male:female
ratio (m:f) of 1 84: 1. This difference was
almost entirely because of the male excess in
CL[P] cases with no associated abnormalities
(m:f= 74:29, YMX2= 188, p<<001). In the
CP group 81/147 (55-1%) of all cases were
female (m:f=0 81:1, yMX2=3-11, p>0 05).
Interestingly, the female excess in the CP
group was most prominent in CP cases with-
out associated abnormalities (m:f= 0-65: 1) and
in cases with Pierre-Robin sequence (PRS)
without additional abnormalities (m:f 0-36: 1).
These differences were not statistically signi-
ficant.
Table 2 Sex distribution in the facial cleft subgroups
Facial cleft ICA Male ICA Female MCA Male MCA Female
CL[P] 74* 29 16 20
CL 35* 11 3 2
CLP 39* 18 13 18
CP (total) 35 54 31 27
Pierre-Robin sequence (PRS) 5 14 4 0
CP (excl PRS) 30 40 27 27
* Highly significant excess of male cases (p < 0 01); CL = cleft lip only; CLP = cleft lip with cleft
palate; CL[P] = cleft lip with or without cleft palate; CP= cleft palate only; ICA = cases in which
the facial cleft was an isolated congenital anomaly; MCA=cases in which the facial cleft was
associated with another major congenital anomaly.
GEOGRAPHICAL AND SEASONAL DISTRIBUTION OF
BIRTHS
Case distribution assessed by the Health Board
of residence of the mother at the time of birth
showed no statistically significant differences
in TBP or LBP. There was no evidence of
significant seasonal variation or cyclical trend
in either group (data not shown).
OUTCOME
Thirteen of 139 (9-3%) cases in the CL[P]
group were stillborn; 10/126 (7-9%) liveborn
CL[P] cases had died by 1 January 1990; 8/10
had major associated anomalies; 5/147 (3 4%)
cases in the CP group were stillborn; 14/142
(9 7%) of the liveborn children with CP had
died by 01/01/90 and all had major associated
abnormalities. The proportions of stillbirths
and early deaths were not significantly dif-
ferent in the two groups.
ASSOCIATED ABNORMALITIES
Thirty six of 139 (25-9%) of the CL[P] group
and 58/147 (39 5%) of the CP group had one
or more major congenital anomaly associated
with their facial cleft. Minor congenital anom-
alies were present in an additional 12/139
(8 6%) CL[P] and 28/147 (19%) CP cases.
Single gene defects, chromosomal aberrations
and identifiable malformation syndromes
accounted for 5 7%, 3 6% and 5 7% in the
CL[P] group and 8-2%, 5-4%, and 20-4% in
the CP group respectively. In only one CP case
was a teratogenic agent (ethanol) thought to be
responsible for the facial cleft. A further 17/
139 (12-2%) in the CL[P] group and 22/147
(14-8%) of the CP group had associated major
malformations that could not be identified as
part of a particular syndrome. The remaining
cases (10/48 CL[P] and 14/86 CP) had single
associated minor abnormalities. The known
diagnoses in both groups are summarised in
table 3.
Discussion
Much of the data reported here are similar to
those reported from other European popula-
tions. In particular, TBP of facial clefts,241631' 32
laterality of lip defects,'0 12 sex ratio differences
of the subgroups,'012 and outcome data33 are
apparently consistent findings that have been
the subject of several excellent reviews'01234
and, therefore, will not be discussed further.
Our data, however, do differ significantly from
previous reports in the proportion of cases
with associated major congenital abnormalities
(AMCA) and in the relative frequency of
CL[P] and CP in the cohort.
Comparing AMCA incidences between
studies is difficult owing to the lack of a rigor-
ous definition of terms used to describe such
anomalies35 (for example, uncomplicated mic-
rognathia in Pierre-Robin sequence). How-
ever, given these limitations there is a remark-
able range in the proportion of cases with
AMCA between apparently well ascertained
cohorts (table 4, 2-9 to 22-8% for CL[P] and
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Table 3 Genetic diagnoses in the facial cleft group
Category Disorder in CLLP! Disorder in CP
group group
Autosomal dominant Myotonic dystrophy Myotonic dystrophy
Van der Woude syndrome (2) Van der Woude syndrome
Hay-Wells syndrome Stickler syndrome (2)
Popliteal web syndrome Ectrodactyly-ectodermal
dysplasia-clefting syndrome
Greig syndrome Velocardiofacial syndrome
Treacher Collins syndrome
Crouzon syndrome
Autosomal recessive Hypertelorism-microtia- Campomelic syndrome
clefting syndrome Diastrophic dysplasia
Kneist dysplasia
X linked X linked hydrocephalus Orofaciodigital type I
Chromosomal Trisomy 13 (3) Trisomy 18 (2)
46,X, + t(10;X) Trisomy 18 mosaic
46,XX,3q + 46,XY,9p +
46,XY,t(3;5;9) + t(6;17)
45,X,-9-X, + t(9;X)
46,XY,del(1 1)(q21 -23)
Malformation syndromes Schisis association (3) Schisis association (4)
Holoprosencephaly Pierre-Robin sequence (23)
lst/2nd arch syndrome (2) lst/2nd arch syndrome (2)
Di George syndrome VATER association
Dandy-Walker syndrome
6-5 to 38-0% for CP) with the present study
appearing to have the highest incidence of
AMCA (26% CL[P] and 39 5% CP) among
the groups chosen for comparison. Possible
explanations for these differences will be dis-
cussed below. The nature of the AMCA
reported in these studies is also of importance
when comparing these data and may give clues
to the pathogenesis of these disorders. This
information has, however, been generally less
well documented, presumably because of the
heterogeneous nature of these anomalies. In
the present study 55% (58% CL[P], 53-5%
CP) of the cases with AMCA had a cytogene-
tic, DNA based, or syndrome diagnosis leav-
ing a significant minority of cases without a
specific diagnosis. In a study of 1000 patients
referred to a centre specialising in the treat-
ment of craniofacial disorders, Shprintzen et
all4 reported similar results with 41% of CL[P]
and CP cases with AMCA having no specific
diagnosis.
The CL[P]:CP ratio provides a convenient
method for observing differences in subgroup
distribution between populations. In Euro-
pean populations the average TBP is about
10/.. for CL[P] and 0-50/0. for Cpl° 12 thus giving
a predicted CL[P]:CP ratio of approximately 2.
It is evident from the ratios derived from seven
widely quoted reports (table 4) that the Scots
and the Finns3' have significantly lower ratios
than the rest of the group (p<0-01). Other
Scottish2223 and Finnish'3 studies have shown
similarly low CL[P]:CP ratios. As the overall
TBP in these reports are similar, it would
appear that the altered CL[P]:CP ratios in
Scotland and Finland are the result of both
"too many" CP cases and "too few" CL[P]
cases. The CL[P]:CP ratio of those cases with
facial cleft as an isolated congenital anomaly
(ICA) and those with AMCA were also com-
pared (table 4). The CL[P]:CP ratio in the ICA
group in all the studies was found to be higher
than that in either the combined group or the
AMCA group; however, the ratio in the Finns
and the Scots remain significantly below the
European average (p < 0 01). Interestingly, the
ICA CL[P]:CP ratio from the Hungarian
population5 appears to be significantly higher
(p < 001) than other reports.
There are three possible explanations for
these results, none of which is mutually exclu-
sive. Firstly the results could be artefactual,
secondly, a specific environment influences the
numbers of cases with AMCA and the
CL[P]:CP ratio, and, thirdly, the differences
are because of the populations being genetic-
ally heterogeneous. The studies chosen for
comparison (table 4) used standard, multiple
source techniques of ascertainment and were
carried out by respected investigators so it
would seem unlikely that the observed dif-
ferences are the result of biased ascertainment.
Evidence that environmental or genetic fac-
tors or both may influence the CL[P]:CP ratio
comes from a study in which Beckman and
Myrberg37 observed that it varied inversely
with latitude in Sweden. They found the ratio
to be 1-46:1 in northern counties, 182:1 in
central counties, and 3-72:1 in southern coun-
ties with similar TBP in each group. Thus the
factors acting on the Scottish and Finnish
populations producing low CL[P]:CP ratios
may be a result of their location in northern
latitudes. The lack of seasonal variation in
both the present study and previous re-
ports,3940 however, implies that any exogenic
factors acting on these populations are not
directly related to temperature, weather, or
daylight effects. Although the identification of
specific environmental factors acting on popu-
lations has proven difficult, the reduction in
recurrence of facial clefts born to women who
had taken periconceptional multivitamin sup-
plementation4' may suggest an aetiological or
corresponding role for dietary factors.
The regional differences in CL[P]:CP ratio
and the proportion of facial cleft cases with
AMCA could also reflect genetic differences in
these populations. The prospect of elucidating
such hereditary factors involved in facial cleft-
ing has been enhanced by the discovery of an
association between both isolated CL[P] and
Table 4 CL[P]:CP ratios in European populations
Study population Year TBP Total No CLIIP]:CP CLfP]:CP CL/Pj:CP ratio of cases
cases ratio No of cases with AMCA without AMCA
CLI PJ :CP
English3" 1962 1 42 386:188 2 05 20:23 2 21
Canadian'S* 1969 1 63 493:244 202 NR
Swedish37 1972 1 72 296:140 2 11 NR
Finnish3' 1974 1 69 289:298 0 97 57:66 1 00
Hungarian5 1980 1-67 1407:588 2 39 321:223 2 97
French4 1982 1-52 121:71 1 71 17:27 2-36
Danish38 1988 1-88 492:186 2 65 14:12 2 74
Scottisht 1992 1-53 139:147 0 94 36:58 1-16
* These data refer to white (non-Indian) cases. tPresent study. TBP= birth prevalence per 1000 total births. CL[P] = cleft lip with or without cleft palate. CP= cleft
palate only. AMCA = associated major congenital anomalies.
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CP and a genetic variation in the TGF a
gene.182' It may be possible in the future to
show genetic differences between facial cleft
groups in different populations that will
explain the CL[P]:CP ratio using this or other
candidate gene probes. We are currently
undertaking such a study in our population.
In conclusion, we cannot explain the dif-
ferences in subgroup ratios and associated ab-
normalities found in European populations;
however, it would appear that the commonly
held assumption that there is little or no varia-
tion in the birth prevalence of CP9'° is incor-
rect. To advance our understanding of the
constellation of abnormalities that are associ-
ated with facial clefts it will be necessary to
collect a large, well documented cohort of
patients with facial clefts as part of multiple
congenital anomalies in the hope that new
diagnostic categories could be identified. This
will certainly be a useful future role for pro-
jects such as the EUROCAT registers. Facial
clefts have been one of the most intensely
studied of human malformations with almost
every report raising more questions than it has
answered. This study follows the tradition and
we hope that it will stimulate further research.
We would like to thank Drs John Tolmie and Rosemarie
Davidson for their invaluable help with syndrome identifica-
tion and Dr David Stone for access to information stored on
the Glasgow EUROCAT register and Dr Susan Cole (CSA,
Trinity House, Edinburgh) for access to the SMR database
information.
I O'Rahilly R, Muller F. Development stages in human em-
bryos. Washington: Camegie Institute of Washington,
1987.
2 Fogh-Andersen P. Inheritance of hare lip and cleft palate.
Copenhagen: Munksgaard, 1942.
3 Fujino H, Tanaka K, Sanui Y. Genetic studies of cleft lips
and cleft palate based on 2828 Japanese cases. Kyushu
Med Sci 1963;14:317-31.
4 Bonaiti C, Briard ML, Feingold J, et al. An epidemiological
and genetic study of facial clefting in France. I Epidemi-
ology and frequency in relatives. Med Genet 1982;19:8-
15.
5 Czeizel A. Cleft lip and cleft palate in East European
populations. In: Melnick M, Bixler D, Shields ED, eds.
Etiology of cleft lip and cleft palate. New York: Alan R
Liss, 1980:249-96.
6 Neel JV. A study of major congenital defects in Japanese
infants. Am Hum Genet 1958;10:398-445.
7 Tretsven VE. Incidence of cleft lip and palate in Montana
Indians. Speech Hear Disord 1963;28:52-7.
8 Longnecker CG, Ryan RF, Vincent R. The incidence of
cleft lip and cleft palate in Charity Hospital. Plast
Reconstr Surg 1965;35:548-50.
9 Chung CS, Myrianthopoulus NC. Racial and prenatal
factors in major congenital malformations. Am Hum
Genet 1968;20:44-60.
10 Shapiro BL. The genetics of cleft lip and palate. In: Stewart
RE, Prescott GH, eds. Oral facial genetics. St Louis:
Mosby, 1976:473.
11 Tenconi R, Clementi M, Turolla L. Theoretical recurrence
risk for cleft lip derived from a population of consecutive
newboms. J Med Genet 1988;25:243-6.
12 Fraser FC. The genetics of cleft lip and cleft palate. Am J
Hum Genet 1970;22:336-52.
13 Rollnick BR, Pruzansky S. Genetic services at a centre for
craniofacial anomalies. Cleft Palate J 1981;18:304-13.
14 Shprintzen RJ, Seigel-Sadewitz VL, Amato J, Goldberg
RB. Anomalies associated with cleft lip, cleft palate or
both. Am J Med Genet 1985;20:585-95.
15 Woolf CM. Congenital cleft lip. J Med Genet 1971;8:65-7 1.
16 Rintala AE. Epidemiology of orofacial clefts in Finland: a
review. Ann Plast Surg 1986;17:456-9.
17 Van der Woude A. Fistula labii inferioris congenita and its
association with cleft lip and palate. Am Jf Hum Genet
1954;6:244-56.
18 Ardinger HH, Buetow KH, Bell GI, Bardach J, VanDe-
mark DR. Association of genetic variation of the trans-
forming growth factor-alpha gene with cleft lip and
palate. Am J Hum Genet 1989;45:348-53.
19 Chenevix-Trench G, Jones K, Green A, Martin N. Further
evidence for an association between genetic variation
between transforming growth factor alpha and cleft lip
and palate. Am J Med Genet 1991;48:1012-13.
20 Holder SE, Vintiner GM, Malcolm S, Winter R. Non-
syndromic cleft lip and palate: association and linkage
studies with the TGF alpha gene. HGMI 1. Cytogenet
Cell Genet 1991;58:1869A.
21 Shiang R, Lidral AC, Ardinger HH, Murray JC, Buetow
KH. Association of TGFA DNA variants with cleft
lip and palate. HGM11. Cytogenet Cell Genet
1991;58:1872A.
22 Drillien CM, Ingram TTS, Wilkinson EM. The causes and
natural history of cleft lip and palate. Edinburgh: Chur-
chill-Livingstone, 1966.
23 Womersley J, Stone DH. Epidemiology of facial clefts.
Arch Dis Child 1987;62:717-20.
24 Bagatin M. Cleft uvula. Acta Chir Plast 1985;27:202-6.
25 Bagatin M. Submucous cleft palate. J Maxillofac Surg
1985;13:37-8.
26 Iizuka T. High incidence of cleft lip and cleft palate in the
human embryo and early fetus. Okajimus Folia Anat J7ap
1973;50:259-7 1.
27 Czeizel A, Tusnady G. Isolated common congenital abnor-
malities in Hungary. Budapest: Akademiai Kiado, 1984.
28 Edwards JH. The recognition and estimation of cyclic
trends. Ann Hum Genet 1961;25:83-7.
29 Hewitt D, Milner J, Csima A, Pakula A. On Edwards'
criterion of seasonality and a non-parametric alternative.
Br J Prev Soc Med 1971;25:174-6.
30 Smith DW. Classification, nomenclature and naming of
morphologic defects. J Pediatr 1975;87:162.
31 Saxen I, Lahti A. Cleft lip and palate in Finland: incidence,
secular, seasonal, and geographical variations. Teratology
1974;9:217-23.
32 Knox G, Braithwaite F. Cleft lips and palates in Northum-
berland and Durham. Arch Dis Child 1963;38:66-70.
33 Mackeprang M, Hay S. Cleft lip and palate mortality study.
Cleft PalateJ 1972;9:51.
34 Warkany J. Malformations of the face. In: Congenital mal-
formations: notes and comments. Chicago: Year Book
Medical Publishers, 1971:621.
35 Sayetta RB, Weinrich MC, Coston GN. Incidence and
prevalence of cleft lip and palate: what we think we know.
Cleft Palate J 1989;26:243-7.
36 Lowry RB, Renwick DHG. Incidence of cleft lip and palate
in British Columbia Indians. J Med Genet 1969;6:67-9.
37 Beckman L, Myrberg N. The incidence of cleft lip and
palate in northern Sweden. Hum Hered 1972;22:417-22.
38 Jensen BL, Kreiborg S, Dahl E, Fogh-Andersen P. Cleft lip
and palate in Denmark, 1976-1981: epidemiology, vari-
ability, and early somatic development. Cleft Palate J
1988;25:258-69.
39 Lutz KR, Moor FB. A study of factors in the occurrence of
cleft palate. J Speech Dis 1955;20:271.
40 Fraser GR, Calnan JS. Cleft lip and palate: seasonal inci-
dence, birth weight, birth rank, sex, site, associated mal-
formations and parental age. Arch Dis Child 1961;36:420-
3.
41 Tolarova M. Periconceptual supplementation with vitamins
and folic acid to prevent the recurrence of cleft lip. Lancet
1982;ii:217.
129
